Press Releases

16/04 BD Earns Industry Top Honors for Transparency, Resiliency and Partnership PR
10/04 BD to Announce Financial Results for its Second Quarter of Fiscal 2026 PR
10/04 Rick Byrd to Retire from BD PR
09/04 For Women Managing Nighttime Incontinence, Better Sleep and Comfort Start with BD® PureWick® Urine Collection System PR
08/04 BD Delivers Next‑Generation TIPS Innovation to Advance Portal Hypertension Care Across the European Union PR
07/04 When Every Beat Matters, BD Helps Clinicians Eliminate Blind Spots with Continuous, Noninvasive Blood Pressure Insight PR
06/04 Fitch Affirms Zimmer Biomet at 'BBB'; Outlook Stable AQ
01/04 BD Launches AI-Enabled Medication Dispensing System to the European Market PR
11/03 Becton Dickinson and : BD and Sinteco Expand Advanced Robotics Offering to Streamline Pharmacy Operations and Care Quality PU
02/03 BD Pioneers New Standard in Surgical Safety with FDA-Cleared Surgiphor™ 1000mL for Wound Irrigation PR
26/02 Becton, Dickinson and Company Announces Pricing of the Tender Offers and Amounts Accepted for Purchase PR
25/02 Becton, Dickinson and Company Announces Early Tender Results and Upsizing of Offer SubCap and Aggregate Offer Cap PR
24/02 BD to Present at Barclays 28th Annual Global Healthcare Conference PR
23/02 BD Expands Testing Capabilities to Help Clinicians Improve Diagnostic Accuracy and Efficiency PR
20/02 Lanesha Minnix Named General Counsel for BD PR
10/02 Becton, Dickinson and Company Announces Tender Offers for Outstanding Debt Securities PR
09/02 Waters Completes Combination with BD's Biosciences & Diagnostic Solutions Businesses PR
09/02 Becton Dickinson: Fiscal Q1 Earnings Snapshot AQ
09/02 Becton Dickinson and : Earnings Release Q1 FY26 PU
09/02 Becton Dickinson and : Presentation Q1 FY26 PU
09/02 BD Reports First Quarter Fiscal 2026 Financial Results PR
29/01 BD and Envetec Demonstrate Closed-Loop Recycling Solution for Laboratory Plastics in Health Care PR
28/01 BD Board Declares Dividend, Authorizes 10 Million Additional Share Repurchases; BD Completed $250 Million Repurchase to Date in FY26 PR
27/01 BD to Announce Financial Results for its First Quarter of Fiscal 2026 PR
23/01 BD Helps Scientists Advance Immunology and Cancer Research with AI-Powered Insights and Automation PR
No results for this search